Larkberget

Larkberget Dividend

The Dividend of Larkberget (LARK.ST) as of Nov 15, 2026 is 0.20 SEK.

Dividend

0.20SEK

Dividend yield

8.55 %

Last updated:

How much dividend does Larkberget 2026 pay?

According to the latest status from November 2026, Larkberget paid a total of 0.20 SEK per share in dividends within the last 12 months. With the current Larkberget price of 2.34 SEK, this corresponds to a dividend yield of 8.55 %. A dividend is paid times per year.

Larkberget currently offers a dividend yield of about 8.55%.

Historical Larkberget Dividends

A dividend is paid times per year. Last year, the payout months were and July.

Historical Larkberget Dividends
PaydateDividend
0.02SEK
0.20SEK

The Larkberget Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2018
0.00 SEK
Jan 1, 2019
0.00 SEK
Jan 1, 2020
0.00 SEK
Jan 1, 2021
0.00 SEK
Jan 1, 2022
0.00 SEK
Jan 1, 2023
0.00 SEK
Jan 1, 2024
0.00 SEK
Jan 1, 2025
0.20 SEK
The Larkberget Dividend history
YEARDividendYoY
0.20SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—

Larkberget dividend history and estimates

In 2025, Larkberget paid a dividend amounting to 0.20 SEK. Dividend means that Larkberget distributes a portion of its profits to its owners.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2025
0.20 SEK
0.00 SEK

Is the Larkberget Dividend Safe?

Larkberget has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Larkberget dividend payout ratio

In 2025, Larkberget had a payout ratio of -32.04%. The payout ratio indicates the percentage of the company's profits that Larkberget distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
0.00 %
Jan 1, 2019
0.00 %
Jan 1, 2020
0.00 %
Jan 1, 2021
0.00 %
Jan 1, 2022
0.00 %
Jan 1, 2023
0.00 %
Jan 1, 2024
0.00 %
Jan 1, 2025
-32.04 %

Dividend Details

Understanding Larkberget's Dividend Distributions

Larkberget’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Larkberget's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Larkberget's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Larkberget’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Larkberget Stock analysis

What does Larkberget do? CombiGene AB specializes in developing treatments for neurological disorders using gene therapy vectors. The company's platform delivers combinations of transgenes encoding neuropeptide Y (NPY) receptors, galanin, galanin receptors, somatostatin, and somatostatin receptors. CombiGene focuses on an epilepsy treatment utilizing an adeno-associated virus (AAV) vector carrying transgenes for NPY and its Y2 receptor. The firm targets neurological and psychiatric diseases in humans and animals through its gene therapy approach. CombiGene AB's products are developed for the treatment of epilepsy and other neurological conditions. The company's platform is designed to deliver multiple therapeutic elements simultaneously via gene therapy vectors. The firm's focus on AAV vectors carrying specific transgenes reflects its strategy to address complex neurological disorders with targeted gene-based therapies. The company's target segments include patients with neurological and psychiatric diseases requiring innovative treatment options. CombiGene AB's development pipeline centers on epilepsy treatment using NPY and Y2 receptor transgenes. The firm's approach involves creating therapies that combine multiple biological components to address disease mechanisms more effectively. Larkberget is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Larkberget stock

Over the past 12 months, Larkberget paid a dividend of 0.20 SEK . This corresponds to a dividend yield of about 8.55 %. For the coming 12 months, Larkberget is expected to pay a dividend of 0.20 SEK.

The current dividend yield of Larkberget is 8.55 %.

Larkberget paid dividends every year for the past 1 years.

For the upcoming 12 months, dividends amounting to 0.20 SEK are expected. This corresponds to a dividend yield of 8.55 %.

Larkberget is assigned to the 'Health' sector.

To receive the latest dividend of Larkberget from 5/15/2026 amounting to 0.02 SEK, you needed to have the stock in your portfolio before the ex-date on 5/8/2026.

The last dividend was paid out on 5/15/2026.

In the year 2025, Larkberget distributed 0.2 SEK as dividends.

The dividends of Larkberget are distributed in SEK.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — Larkberget